HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Manuel Fuentes Selected Research

Proteome

1/2023Exploring High-Throughput Immunoassays for Biomarker Validation in Rheumatic Diseases in the Context of the Human Proteome Project.
1/2018A Perspective on Proteomics of Infectious Diseases.
1/2017Proteomic Biomarker Identification in Cerebrospinal Fluid for Leptomeningeal Metastases with Neurological Complications.
9/2015Integration of Proteomics and Transcriptomics Data Sets for the Analysis of a Lymphoma B-Cell Line in the Context of the Chromosome-Centric Human Proteome Project.
6/2015Association of chromosome 19 to lung cancer genotypes and phenotypes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Manuel Fuentes Research Topics

Disease

18Neoplasms (Cancer)
04/2024 - 12/2005
8Alzheimer Disease (Alzheimer's Disease)
02/2022 - 01/2014
7Gestational Diabetes (Gestational Diabetes Mellitus)
12/2020 - 09/2012
5Neoplasm Metastasis (Metastasis)
04/2024 - 01/2013
5Infections
01/2023 - 12/2012
5Osteosarcoma (Osteogenic Sarcoma)
04/2018 - 02/2014
4Bipolar Disorder (Manic Depressive Psychosis)
02/2024 - 02/2015
4Colorectal Neoplasms (Colorectal Cancer)
03/2023 - 01/2013
4Disease Progression
01/2023 - 06/2015
3Mania (Manias)
02/2024 - 02/2015
3B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2023 - 06/2017
3Rheumatoid Arthritis
01/2023 - 11/2014
3Osteoarthritis
01/2023 - 11/2014
3COVID-19
11/2022 - 01/2022
2Cardiotoxicity
01/2023 - 01/2023
2Inflammation (Inflammations)
01/2023 - 11/2022
2B-Cell Lymphoma (Lymphoma, B Cell)
11/2021 - 09/2015
2Communicable Diseases (Infectious Diseases)
01/2021 - 01/2018
2Pregnancy-Induced Hypertension (Hypertension, Pregnancy Induced)
05/2019 - 01/2017
2Wounds and Injuries (Trauma)
05/2019 - 01/2017
2Gestational Weight Gain
05/2019 - 01/2017
2Mental Disorders (Mental Disorder)
08/2016 - 09/2015
2Psychotic Disorders (Schizoaffective Disorder)
01/2016 - 12/2015
1Cardiovascular Diseases (Cardiovascular Disease)
11/2023
1Coronary Artery Disease (Coronary Atherosclerosis)
11/2023
1Diabetes Mellitus
11/2023
1Heart Failure
11/2023
1Lymphocytosis
01/2023
1Respiratory Tract Infections (Respiratory Tract Infection)
01/2023
1Frailty
01/2023
1Psoriatic Arthritis
01/2023
1Rheumatic Diseases (Rheumatism)
01/2023
1Leukemia
01/2022
1Lymphoma (Lymphomas)
01/2022
1Sepsis (Septicemia)
01/2022
1Pneumonia (Pneumonitis)
01/2022
1Cognitive Dysfunction
01/2021
1Retinal Degeneration
06/2020
1Dementia (Dementias)
01/2020
1Clinical Deterioration
01/2020
1Knee Osteoarthritis
12/2019
1Pre-Eclampsia (Preeclampsia)
05/2019
1Mitochondrial Diseases (Mitochondrial Disease)
10/2018
1Malaria
07/2018

Drug/Important Bio-Agent (IBA)

18Biomarkers (Surrogate Marker)IBA
01/2023 - 01/2013
16Proteins (Proteins, Gene)FDA Link
04/2024 - 12/2012
5AutoantibodiesIBA
01/2023 - 11/2014
5ProteomeIBA
01/2023 - 06/2015
4AldehydesIBA
04/2024 - 04/2018
4Antidepressive Agents (Antidepressants)IBA
02/2024 - 02/2015
4AntigensIBA
01/2023 - 11/2014
4AntibodiesIBA
05/2021 - 12/2005
3Glucose (Dextrose)FDA LinkGeneric
11/2023 - 09/2012
2PlatinumIBA
06/2023 - 07/2017
2Genetic Markers (Genetic Marker)IBA
01/2023 - 01/2023
2AnthracyclinesIBA
01/2023 - 01/2023
2Blood Proteins (Serum Proteins)IBA
01/2023 - 01/2017
2Nucleic AcidsIBA
12/2019 - 11/2014
2Olive OilIBA
01/2019 - 01/2017
2N- (4'- fluorobutyrophenone)- 4- (4- chlorophenyl)pyridinium (HPP(+))IBA
01/2018 - 06/2015
2Bile Acids and Salts (Bile Acids)IBA
07/2017 - 02/2014
2Peptides (Polypeptides)IBA
06/2017 - 10/2012
2oxovanadium IVIBA
01/2017 - 01/2016
2Insulin (Novolin)FDA Link
01/2017 - 09/2012
1Phosphotransferases (Kinase)IBA
04/2024
1Antimitotic AgentsIBA
04/2024
1Sodium-Glucose Transporter 2 InhibitorsIBA
11/2023
1SodiumIBA
11/2023
1IronIBA
06/2023
1Immunoglobulin G (IgG)IBA
01/2023
1SuspensionsIBA
01/2023
1Immunoglobulin M (IgM)IBA
01/2023
1Immunoglobulins (Immunoglobulin)IBA
01/2023
1Immunoglobulin A (IgA)IBA
01/2023
1Acute-Phase Proteins (Acute-Phase Protein)IBA
11/2022
1Presenilin-1IBA
02/2022
1Oxygen (Dioxygen)IBA
01/2022
1CytokinesIBA
01/2022
1Immunologic Factors (Immunomodulators)IBA
01/2022
1RNA (Ribonucleic Acid)IBA
11/2021
1EpitopesIBA
07/2021
1HLA Antigens (Human Leukocyte Antigens)IBA
01/2021
1Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2021
1Amyloid beta-PeptidesIBA
01/2021
1HLA-A Antigens (HLA-A)IBA
01/2021
1Type II DNA Topoisomerases (Topoisomerase II)IBA
09/2020
1Etoposide (VP 16)FDA LinkGeneric
09/2020
1TubulinIBA
09/2020
1Neuroprotective AgentsIBA
06/2020
1quinone (benzoquinone)IBA
10/2018
1hydroquinone (Esoterica)FDA Link
10/2018
1NeurograninIBA
05/2018
1Amyloid (Amyloid Fibrils)IBA
01/2018

Therapy/Procedure

6Mediterranean Diet
12/2020 - 01/2017
5Therapeutics
01/2022 - 08/2013
2Immunotherapy
06/2022 - 07/2021
2Activities of Daily Living (ADL)
01/2020 - 11/2015
2Cesarean Section (Caesarean Section)
05/2019 - 01/2017
1Radiotherapy
01/2022
1Nutrition Therapy (Medical Nutrition Therapy)
01/2018